Rationale and protocol design for the TORG1835/NEXT-SHIP study: a phase II study of carboplatin, etoposide and nintedanib for unresectable limited/extensive disease small cell lung cancer with idiopathic pulmonary fibrosis
Ikeda, Satoshi, Ogura, Takashi, Kato, Terufumi, Kenmotsu, Hirotsugu, Iwasawa, Tae, Misumi, Toshihiro, Yamanaka, Takeharu, Okamoto, HiroakiVolume:
12
Journal:
Therapeutic Advances in Medical Oncology
DOI:
10.1177/1758835920923431
Date:
January, 2020
File:
PDF, 222 KB
2020